text.skipToContent text.skipToNavigation

QIAseq Targeted RNA Virtual Panels

Digital RNA-seq for gene expression profiling

  • Start with 25 ng cDNA or 25 ng of total RNA for each panel
  • Unique Molecular Indices (UMIs) ensure accurate expression profiling
  • Go from sample to sequence-ready library in a single day
  • Cloud-based data analysis via GeneGlobe Data Analysis Centre
  • On-site data analysis provided through CLC Biomedical Workbench

QIAseq Targeted RNA Virtual Panels have been developed as a Sample to Insight solution for quantitative gene expression profiling using RNAseq. These panels integrate molecular barcode technology and a two-stage PCR-based library preparation to deliver unbiased and accurate quantification for your digital RNA sequencing results. 

The QIAseq Targeted RNA Virtual Panels build on QIAGEN’s know-how to deliver more than 170 panels with biologically- and disease-relevant gene content. These panels have been curated over several years by mining literature and accessing QIAGEN's proprietary knowledge database.



Need a quote for your research project or would you like to discuss your project with our specialist team? Contact Us
Product Product no. Cat. no. List price:
 
 
Show details 		    varies
Can't order online?
To place an order via phone, email or for requesting a quote, please provide the product’s name, number and catalog number.
Adherens Junctions

Show products
Adipogenesis

Show products
Aging

Show products
Allergy and Asthma

Show products
Alzheimers Disease

Show products
Amino Acid Metabolism I

Show products
Amino Acid Metabolism II

Show products
AMPK Signaling

Show products
Androgen Receptor Signaling Targets

Show products
Angiogenesis

Show products
Angiogenic Growth Factors

Show products
Antibacterial Response

Show products
Antifungal Response

Show products
Antiviral Response

Show products
Apoptosis

Show products
Apoptosis 384HT

Show products
Atherosclerosis

Show products
Autophagy

Show products
Breast Cancer

Show products
cAMP Calcium Signaling PathwayFinder

Show products
Cancer Drug Resistance

Show products
Cancer Drug Targets

Show products
Cancer Inflammation and Immunity Crosstalk

Show products
Cancer PathwayFinder

Show products
Cancer Stem Cells

Show products
Cardiotoxicity

Show products
Cardiovascular Disease

Show products
Cell Cycle

Show products
Cell Death PathwayFinder

Show products
Cell Junction PathwayFinder

Show products
Cell Lineage Identification

Show products
Cell Motility

Show products
Cell Surface Markers

Show products
Cellular Senescence

Show products
Cellular Stress Responses

Show products
Chemokines and Receptors

Show products
Circadian Rhythms

Show products
Common Cytokines

Show products
Crohns Disease

Show products
Cystic Fibrosis

Show products
Cytokines and Chemokines

Show products
Cytoskeleton Regulators

Show products
Dendritic and Antigen Presenting Cell

Show products
Diabetes

Show products
DNA Damage Signaling Pathway

Show products
DNA Repair

Show products
Dopamine and Serotonin Pathway

Show products
Drug Metabolism

Show products
Drug Metabolism Phase I Enzymes

Show products
Drug Metabolism Phase II Enzymes

Show products
Drug Transporters

Show products
EGF PDGF Signaling Pathway

Show products
Embryonic Stem Cells

Show products
Endothelial Cell Biology

Show products
Epigenetic Chromatin Modification Enzymes

Show products
Epigenetic Chromatin Remodeling Factors

Show products
Epithelial to Mesenchymal Transition

Show products
Estrogen Receptor Signaling

Show products
Extracellular Matrix and Adhesion Molecules

Show products
Fatty Acid Metabolism

Show products
Fatty Liver

Show products
Female Infertility

Show products
Fibrosis

Show products
Focal Adhesions

Show products
GABA and Glutamate

Show products
Gap Junctions

Show products
Glucocorticoid Signaling

Show products
Glucose Metabolism

Show products
Glycosylation

Show products
G Protein Coupled Receptors 384HT

Show products
GPCR Signaling PathwayFinder

Show products
Growth Factors

Show products
Heat Shock Proteins and Chaperones

Show products
Hedgehog Signaling Pathway

Show products
Hematopoiesis

Show products
Hepatotoxicity

Show products
Hippo Signaling Pathway

Show products
HIV Host Response

Show products
Homeobox HOX Genes

Show products
Huntingtons Disease

Show products
Hypertension

Show products
Hypoxia Signaling Pathway

Show products
Hypoxia Signaling Pathway Plus

Show products
IL6STAT3 Signaling Pathway

Show products
IL6STAT3 Signaling Pathway Plus

Show products
Immunotoxicity

Show products
Induced Pluripotent Stem Cells

Show products
Inflammasomes

Show products
Inflammatory Cytokines and Receptors

Show products
Inflammatory Response and Autoimmunity

Show products
Inflammatory Response and Autoimmunity 384H

Show products
Innate and Adaptive Immune Responses

Show products
Insulin Resistance

Show products
Insulin Signaling Pathway

Show products
Interferons and Receptors

Show products
JAK STAT Signaling Pathway

Show products
let-7a Targets

Show products
Leukemia

Show products
Lipoprotein Signaling and Cholesterol Metabolism

Show products
Liver Cancer

Show products
Lung Cancer

Show products
Lymphoma

Show products
Macular Degeneration

Show products
Male Infertility

Show products
MAP Kinase Signaling Pathway

Show products
Mesenchymal Stem Cells

Show products
miR-1 and miR-206 Targets

Show products
miR-146a Targets

Show products
miR-153 Targets

Show products
miR-155 Targets

Show products
miR-17 and miR-20a Targets

Show products
miR-181 Targets

Show products
miR-21 Targets

Show products
miR-210 Targets

Show products
miR-221 and miR-222 Targets

Show products
miR-29 Targets

Show products
miR-34a Targets

Show products
miR-4514 and miR-4692 Targets

Show products
miR-9 Targets

Show products
Mitochondria

Show products
Mitochondrial Energy Metabolism

Show products
Mitochondrial Energy Metabolism Plus

Show products
Molecular Toxicology PathwayFinder

Show products
Molecular Toxicology PathwayFinder 384HT

Show products
mTOR Signaling

Show products
Multiple Sclerosis

Show products
MYC Targets

Show products
Necrosis

Show products
Nephrotoxicity

Show products
Neurogenesis

Show products
Neuronal Ion Channels

Show products
Neurotoxicity

Show products
Neurotransmitter Receptors

Show products
Neurotrophins and Receptors

Show products
NFkB Signaling Pathway

Show products
NFkB Signaling Pathway Plus

Show products
NFkB Signaling Targets

Show products
Nitric Oxide Signaling Pathway

Show products
Notch Signaling Pathway

Show products
Notch Signaling Pathway Plus

Show products
Notch Signaling Targets

Show products
Nuclear Receptors and Coregulators

Show products
Obesity

Show products
Oncogenes and Tumor Suppressor Genes

Show products
Osmotic Stress

Show products
Osteogenesis

Show products
Osteoporosis

Show products
Oxidative Stress

Show products
Oxidative Stress Plus

Show products
p53 Signaling Pathway

Show products
Pain Neuropathic and Inflammatory

Show products
Parkinsons Disease

Show products
Phagocytosis

Show products
PI3K-AKT Signaling Pathway

Show products
Polycomb and Trithorax Complexes

Show products
Polycomb and Trithorax Target Genes

Show products
Polycystic Kidney Disease

Show products
PPAR Targets

Show products
Pre-Eclampsia

Show products
Primary Cilia

Show products
Prostate Cancer

Show products
Protease Activated Receptor Signaling

Show products
Protein Phosphatases

Show products
Retinoic Acid Signaling

Show products
Signal Transduction PathwayFinder

Show products
Skeletal Muscle Myogenesis and Myopathy

Show products
Stem Cell

Show products
Stem Cell Signaling

Show products
Stem Cell Transcription Factors

Show products
Stress and Toxicity PathwayFinder

Show products
Synaptic Plasticity

Show products
T Cell Anergy and Immune Tolerance

Show products
T-Cell and B-Cell Activation

Show products
Telomeres and Telomerase

Show products
Terminal Differentiation Markers

Show products
TGFb BMP Signaling Pathway

Show products
TGFb Signaling Targets

Show products
T Helper Cell Differentiation

Show products
Th1 and Th2 Responses

Show products
Th17 Response

Show products
Tight Junctions

Show products
TNF Signaling Pathway

Show products
Toll-Like Receptor Signaling Pathway

Show products
Transcription Factors

Show products
Transplant Rejection

Show products
Tumor Metastasis

Show products
Type I Interferon Response

Show products
Tyrosine Kinases

Show products
Ubiquitin Ligases

Show products
Ubiquitination Ubiquitinylation

Show products
Unfolded Protein Response

Show products
Unfolded Protein Response Plus

Show products
VEGF Signaling

Show products
WNT Signaling Pathway

Show products
WNT Signaling Pathway Plus

Show products
WNT Signaling Targets

Show products
Wound Healing

Show products
Configure
Product Product no. Cat. no. List price:
 
 
Show details 		    varies
Can't order online?
To place an order via phone, email or for requesting a quote, please provide the product’s name, number and catalog number.

QIAseq Targeted RNA Virtual Panels are intended for molecular biology applications. These products are not intended for the diagnosis, prevention, or treatment of a disease.


0
Digital sequencing (molecular barcodes) principle

QIAseq Targeted RNA Panels use a digital sequencing method, whereby a unique 12-base random molecular barcode incorporated into the gene-specific primers (GSP1) is used in the first extension step (after mRNA is converted to cDNA). Thus, every extension event yields a unique combination of molecular barcode and target sequence. At the end of sequencing, the relative amount of each mRNA target is determined by the number of unique molecular barcode-target combinations that were sequenced, thereby eliminating PCR duplicates and amplification bias, resulting in more accurate, unbiased gene expression analysis.

1
One solution to overcome the challenges of gene expression profiling

The QIAseq Targeted RNA Panels have been developed as a Sample to Insight solution for quantitative gene expression profiling using RNAseq. The panels use molecular barcodes and a two-stage PCR-based integrated library preparation to overcome the challenge of PCR duplicates and amplification bias to deliver unbiased, accurate and reproducible gene expression results.

2
Unbiased and accurate gene quantification (A)

Different amounts (20 ng, 5 ng or 1.25 ng) of universal reference RNA were used to determine expression levels of three genes (BNIP1, CTNND2 and DAPK1) using targeted RNAseq. QIAseq digital RNA sequencing method (A; molecular barcode counts) showed accurate quantification of all three genes corresponding to different RNA input, whereas traditional targeted RNAseq (B; read counts) revealed PCR duplication limitation and yielded inaccurate quantification.

3
Unbiased and accurate gene quantification (B)
Different amounts (20 ng, 5 ng or 1.25 ng) of universal reference RNA were used to determine expression levels of three genes (BNIP1, CTNND2 and DAPK1) using targeted RNAseq. QIAseq digital RNA sequencing method (A; molecular barcode counts) showed accurate quantification of all three genes corresponding to different RNA input, whereas traditional targeted RNAseq (B; read counts) revealed PCR duplication limitation and yielded inaccurate quantification.
4
Proprietary primer design delivers gene-specific amplicons (>97% specificity)

Sequencing libraries were prepared using 1.25, 5 or 20 ng universal reference RNA and QIAseq Targeted RNA Panels, ranging from 12-plex to 1000-plex. Sequencing was performed on the Illumina MiSeq, dedicating 1 million reads per sample. Specificity is calculated as percent of trimmed and mapped reads that map to intended targets.

5
Unmatched uniformity (>97% of assays are within 20% of median molecular tag counts)
A 917-plex gene panel was used to prepare a library from 10 ng of NA12878 reference DNA. All assays were designed to be intra-exon, and are thus single copy on genomic DNA. This allows an estimation of the uniformity of amplicon performance in the library preparation step (e.g., every unique tag equals one captured copy). In terms of raw assay performance, 97.5% of assays are within 20% of mean/median molecular tag counts. For cataloged panels, any assay below 20% is redesigned and replaced. Molecular barcodes entirely remove this variation in RNAseq counting.
6
Simple procedure

Starting with 25 ng of total unfragmented RNA, cDNA is synthesized, and each cDNA molecule is tagged with a unique molecular barcode before any amplification. The uniquely tagged cDNA molecules then undergo a two-stage PCR step for enrichment and library construction. It takes only 6 hours from RNA sample to targeted library ready for sequencing.

7
Positive results with as little as 0.2 copies of RNA per cell

ERCC standards, at 86 to 705,500 copies, spiked into universal reference RNA sample and enriched using 384-plex QIASeq Targeted RNA Panel in three technical replicates. (A) Sensitivity measurement. Under standard conditions (20 ng RNA input, 0.5 million MiSeq reads), ≥~100 copies of ERCC transcripts were reliability detected, which is the equivalent of ~0.2 copies per cell. (B) Precision measurement. At >10 barcodes/gene, CV was less than 5% for all targets, indicating high technical reproducibility. This corresponds to ~100 copies target RNA in the sample.

8
High concordance with qPCR
Expression levels for 384 genes were determined by both QIAseq Targeted RNA Panel and qPCR for Human Brain Reference RNA (HBRR) and Universal Human Reference RNA (UHRR) samples. The expression levels determined by qPCR were normalized to the average of four housekeeping genes (ACTB, B2M, GAPDH and RPLP0) and fold change between the samples was calculated (HBRR/UHRR) for each gene. For QIAseq, the number of unique molecular barcodes per gene were counted and normalized to average number of molecular barcodes for the four housekeeping genes for each sample. The fold change for each gene was then calculated. The QIAseq Targeted RNA Panel and qPCR assays exhibit similar fold-changes in gene expression, highlighting the accuracy of QIAseq-results.
Performance

Principle
  • Traditional RNA sequencing methods suffer from PCR duplication and amplification bias, resulting in inaccurate gene expression analysis. By introducing molecular barcodes before any amplification takes place, QIAseq Targeted RNA Panels are able to eliminate this issue to deliver accurate and digital quantification of genes (see figure Unbiased and accurate gene quantification).
  • A unique feature of the QIAseq Targeted RNA Panels is the set of built-in control assays. The gDNA assays control for any gDNA contamination in the RNA sample to ensure reproducible results. The housekeping gene (HKG) assays are used to normalize data, thereby making sample-to-sample and run-to-run comparisons possible.

 

Procedure
  • The QIAseq Targeted RNA Panels workflow begins with converting total RNA into cDNA (see figure Simple procedure). The workflow requires minimal RNA input: as little as 25 ng total RNA can be used. No enrichment or depletion steps are necessary. The molecular barcoding step makes use of molecularly barcoded gene-specific primer (GSP1) in a multiplex primer panel (targeting 12-1000 genes) and an input of 20ng of cDNA equivalent (cDNA made from 20 ng of total RNA). After the barcoding step, the uniquely tagged cDNA is purified over beads to remove residual primers, and a PCR is set up with a second pool of gene-specific adapter primers (GSP2) and the RS2 primer, which primes off of a common tag on the GSP1 primers. This reaction insures that intended targets are enriched sufficiently to be represented in the final library. The number of cycles is kept to a minimum to keep PCR-induced variations in amplification to a low level (any variations are easily corrected and accounted for with the molecular barcodes). Another quick cleanup with beads is performed, and a universal PCR is run with RS2 and FS2 primers, which also adds sample-indexing barcodes to each sample. A final cleanup with beads is performed and the library is complete, and ready for quantification and sequencing.
  • An integral component of the QIAseq Targeted RNA Panels is data analysis and insight. Data analysis modules have been developed that are comprehensive, yet easy to use. Using these modules require no bioinformatics expertise. Starting with raw reads directly off the sequencer, the QIAseq targeted RNA data analysis tools at QIAGEN’s GeneGlobe portal, provide you with gene counts and fold changes, as well as links for pathway analysis.
Applications
  • Gene expression profiling
  • Biomarker research
  • Confirmation of whole transcriptome sequencing data
  • Confirmation of microarray data
fragment fix placeholder
Sample to Insight
© QIAGEN 2013–2018. All rights reserved.